| 摘要: |
| 1型糖尿病（type 1 diabetes mellitus，T1DM）是一种由于胰岛β细胞损伤，导致胰岛素绝对缺乏的自身免疫性疾病。良好的血糖控制可以降低T1DM患者并发症的发生风险，技术进步是T1DM患者实现良好血糖管理的重要前提。随着连续血糖监测系统（continue glucose monitoring system，CGMS）的进一步改善，更多、更先进的自动胰岛素输送系统的出现，在未来的5年里，T1DM治疗技术有望取得飞速进展。 |
| 关键词: 1型糖尿病 持续皮下输注胰岛素 连续血糖监测系统 |
| DOI：10.11724/jdmu.2021.03.01 |
| 分类号:R587.1 |
| 基金项目:国家科技部科技支撑课题项目（2013BAI09B13） |
|
| Progress in diagnosis and treatment of type 1 diabetes mellitus |
|
WANG Bing, GAO Zhengnan
|
|
Department of Endocrine, Dalian Municipal Central Hospital, Dalian 116033, China
|
| Abstract: |
| Type 1 diabetes (T1DM) is an autoimmune disease characterized by deficient insulin production which due to dysfunction of islet β-cell. Proper glycemic controlhas been thought to prevent or delay the complications of T1DM and technological advances have had an important prerequisite for the management of T1DM. In the next 5 years, with improvements in continuous glucose monitoring and more available choices of systems that automate insulin delivery advances are expected in technology for the management of T1DM. |
| Key words: type 1 diabetes mellitus continuous subcutaneous insulin infusion continue glucose monitoring system |
